AbbVie Inc. (0QCV.IL)
Makes medicines that treat cancer, autoimmune diseases, and chronic conditions like arthritis and migraine.
$265.00+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+37.3%
The outlook
AbbVie is trading near the upper end of its 52-week range and well above its key moving averages, signaling sustained upward momentum. Analyst coverage is bullish overall, though the trailing P/E of 54.5 is notably elevated. The stock's position reflects strong recent performance relative to its yearly lows.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range91% of the way from its 52-week low to high
Market cap
$476.72B
52-wk high
$273.25
52-wk low
$186.05
50-day avg
$236.41
200-day avg
$224.19
Trailing P/E
54.5